Myocardial Infarction News and Research

RSS

Study identifies the link between a gene variant and protection against coronary atherosclerosis

The protective effect of the newly discovered variant against coronary heart disease is likely to be caused by the below-average arterial stiffness of variant carriers.

17 Aug 2022

Researchers unravel a novel molecular target of eicosapentaenoic acid

Eicosapentaenoic acid (EPA) is an essential nutrient belonging to the omega-3 group of polyunsaturated fatty acids (PUFAs). As the human body cannot synthesize PUFAs, dietary supplements containing EPA are required for normal physiological functions. Found abundantly in natural sources like fish, hemp oil, and linseed oil, EPA is known to exhibit anti-inflammatory, neuroprotective, and cardiovascular protective activities.

9 Aug 2022

The impact of cold agglutinin syndrome on clinical presentations in COVID-19

Researchers presented two cases to highlight the impact of cold agglutinin syndrome on clinical presentations in COVID-19.

8 Aug 2022

French study on cardiovascular disease incidence during COVID pandemic and vaccination campaign

Researchers describe failures of the French healthcare system as reflected by increased hospitalizations due to certain acute cardiovascular diseases in 2021.

7 Aug 2022

Experiments and mathematical modeling help study the role of morphogens in tissue patterning

Morphogens are molecules that travel from biological cell to cell to pattern tissues in the embryo. These molecules are important not only for the embryo during development, but also for the adult during tissue repair.

2 Aug 2022

IRB Barcelona researchers discover genetic drivers of clonal hematopoiesis

Clonal hematopoiesis is a biological process in which a blood stem cell (the population that gives rise to a variety of blood cell types) acquires an advantageous mutation and outgrows neighboring cells.

2 Aug 2022

Human anti-desmoglein 2 levels are associated with COVID-19 severity

In a new study, researchers assessed the association between anti-desmoglein (DSG) 1, 2 and 3 auto-antibodies (auto-Abs) in acute and convalescent serum samples obtained from patients with COVID-19 of varying severity.

2 Aug 2022

Two heart drugs may increase the risk of heart attack during hot-weather events

For people with coronary heart disease, beta-blockers can improve survival and quality of life, while aspirin and other antiplatelet medications can reduce the risk of a heart attack.

1 Aug 2022

UK study finds an increase in cardiovascular diseases and diabetes up to 12 months after COVID-19

Researchers determined whether the incidence of new diabetes mellitus (DM) and cardiovascular diseases (CVDs) increases in a year among those recovering from COVID-19.

21 Jul 2022

Smoking increases risk of severe COVID-19 outcomes in hospitalized patients

New research assessed the association of smoking with COVID-19 complications.

20 Jul 2022

Long-established drug for angina pectoris shows anti-inflammatory effect, reduces atherosclerotic plaques

A drug used in the clinical treatment of angina symptoms also has an anti-inflammatory effect and reduces atherosclerotic plaques in blood vessels - thereby reducing the risk of heart attack or stroke.

14 Jul 2022

Nuclear stress testing can help shape physicians' decision to refer patients for heart procedures

Patients identified by nuclear stress testing as having severe stress-induced myocardial ischemia (lack of blood flow to the heart) are likely to benefit from heart bypass surgery or angioplasty, while those with mild or no ischemia are not, according to a new study from the Icahn School of Medicine at Mount Sinai.

11 Jul 2022

What is the optimal LDL cholesterol level for patients with cardiovascular diseases?

In a new study, the effectiveness of low low-density lipoprotein cholesterol levels in reducing the risk of atherosclerotic vascular events was explored.

6 Jul 2022

SARS-CoV-2 infection of lung endothelial cells and pulmonary capillary microthrombosis

Researchers evaluated the presence of RNA of SARS-CoV-2 in lung tissue of deceased patients.

4 Jul 2022

The past, present and future of aspirin in cardiovascular disease prevention

The International Aspirin Foundation A special edition issue of the Aspirin Summaries has been published '125 years of aspirin - the role of aspirin in CVD' issue 2022 .

29 Jun 2022

Researchers develop new method based on magneto-active polymers to study cellular behavior

Scientists from 4D-BIOMAP, an ERC research project at the Universidad Carlos III de Madrid (UC3M), have developed a new experimental method, based on magneto-active polymers, to study cellular behavior.

28 Jun 2022

Women less likely to receive timely treatment for heart attack despite improvements to care

Despite overall improvements to care for a heart attack, women are less likely to receive timely treatment, according to a new study in Annals of Emergency Medicine.

23 Jun 2022

Study shows the safety of COVID-19 vaccines for patients with cardiovascular disease

COVID-19 vaccination is not associated with an increased risk of heart attack or stroke in patients with established cardiovascular disease, according to a large study published today in Cardiovascular Research, a journal of the European Society of Cardiology.

23 Jun 2022

Math model predicts several useful new drug combinations that may help treat heart attacks

Researchers used mice to develop a mathematical model of a myocardial infarction, popularly known as a heart attack.

17 Jun 2022

First-of-its-kind technology repairs and regenerates heart muscle cells

Researchers at the University of Houston are reporting a first-of-its-kind technology that not only repairs heart muscle cells in mice but also regenerates them following a heart attack, or myocardial infarction as its medically known.

16 Jun 2022

Myocardial Infarction News and Research

Study identifies the link between a gene variant and protection against coronary atherosclerosis

Researchers unravel a novel molecular target of eicosapentaenoic acid

The impact of cold agglutinin syndrome on clinical presentations in COVID-19

French study on cardiovascular disease incidence during COVID pandemic and vaccination campaign

Experiments and mathematical modeling help study the role of morphogens in tissue patterning

IRB Barcelona researchers discover genetic drivers of clonal hematopoiesis

Human anti-desmoglein 2 levels are associated with COVID-19 severity

Two heart drugs may increase the risk of heart attack during hot-weather events

UK study finds an increase in cardiovascular diseases and diabetes up to 12 months after COVID-19

Smoking increases risk of severe COVID-19 outcomes in hospitalized patients

Long-established drug for angina pectoris shows anti-inflammatory effect, reduces atherosclerotic plaques

Nuclear stress testing can help shape physicians' decision to refer patients for heart procedures

What is the optimal LDL cholesterol level for patients with cardiovascular diseases?

SARS-CoV-2 infection of lung endothelial cells and pulmonary capillary microthrombosis

The past, present and future of aspirin in cardiovascular disease prevention

Researchers develop new method based on magneto-active polymers to study cellular behavior

Women less likely to receive timely treatment for heart attack despite improvements to care

Study shows the safety of COVID-19 vaccines for patients with cardiovascular disease

Math model predicts several useful new drug combinations that may help treat heart attacks

First-of-its-kind technology repairs and regenerates heart muscle cells

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News